| September 2006 · Vol. 18, No. 9 6 PRACTICE POINTS
Hormonal contraception in women with medical conditions
An interview with Dr. Andrew M. Kaunitz, who assisted in the preparation of the new ACOG Practice Bulletin
|
Fast Track
Women with a family history of breast cancer or BRCA1 or 2 can use the Pill to prevent ovarian cancer without adding to their breast cancer risk
Rifampin is the only antibiotic for which we have solid evidence of substantially lower steroid levels
Combination OCs are safe in lupus patients with stable, mild disease, who are seronegative for antiphospholipid antibodies, with no prior thrombosis
DMPA use by itself is not an indication for bone density measurement
|
|
Andrew
M.
Kaunitz,
MDOBG Management Board of Editors, Professor and Assistant Chairman, Department of Obstetrics and Gynecology, University of Florida College of Medicine–Jacksonville, Jacksonville, Fla
Decisive new data on risks and benefits of hormonal contraception will change how we manage many patients. These findings prompted the American College of Obstetricians and Gynecologists (ACOG) to update its practice bulletin (released in June) on hormonal contraception in women with coexisting medical conditions.1 Among the most notable areas of change:
For the fine points on these and other findings, we talked with Dr. Andrew M. Kaunitz, who assisted ACOG with preparation of the new bulletin.1
|
